It is important to identify inter-observer variation in the interpretation of uptake pattern on thyroid scintigraphy. If clinicians interpret the same scintigram differently, it is likely that they will recommend different treatments. Despite its central role in the management of thyrotoxicosis and its widespread use for many years, there are no published studies of inter-observer variation in interpretation of uptake patterns of thyroid scintigraphy. Therefore, we aimed to assess inter-observer variation in interpretation of thyroid scintigraphy (99mTc-pertechnetate).
Three assessors independently reviewed 99m Tc-pertechnetate thyroid scintigrams. All three assessors were consultant endocrinologists with interests in thyroid disease and 8-14 years of specialist clinical experience. They reviewed images from 173 patients [76% female, median age 60 years (IQR 45-74)], carried out in a single university hospital from Sep 2006 to Aug 2014 for patients with thyrotoxicosis who were negative for TRAb. TRAb was measured using 2nd generation ELISA from EUROIMMUN AG, Germany. Thyroid scintigrams of the patients with borderline or positive TRAb results were excluded from this study. All assessors were unaware of patients' clinical details. All three assessors graded each patient's scintigraphy into one of four patterns-(a) diffuse uptake, (b) diminished or no uptake, (c) patchy uptake, and (d) localised uptake, according to published criteria [1, 3] . If scintigraphy was felt to be compatible with more than one pattern, a single preferred pattern was required. All scintigrams were viewed on a computer screen. Inter-observer agreement was analysed using kappa statistics using StataSE 14.2 (Texas, USA). Kappa is a measure of agreement that is corrected for the agreement that would be expected by chance. It ranges from 0 to 1; 0 represents the amount of agreement that can be expected from random chance, and 1 represents perfect agreement between To the Editor:
Thyroid scintigraphy ( 99m Tc-pertechnetate or radioiodine) is an important investigation to identify the aetiology of thyrotoxicosis. It is widely used as a second-line investigation in thyrotoxic patients who do not have thyroid stimulating hormone receptor antibodies (TRAb) to distinguish between Graves' disease and toxic nodular goitre [1] . It is also used to confirm the diagnosis of thyroiditis in thyrotoxic patients with symptoms suggestive of thyroiditis. However, in some countries it is used as a first-line investigation for identifying aetiology of thyrotoxicosis [1, 2] .
Accurate interpretation of thyroid scintigrams influences treatment decision. The thyroid scintigrams are interpreted for amount and more importantly pattern of uptake of radionuclide in the thyroid gland [1] . There are four main types of pattern and each of them provides clues to aetiology of thyrotoxicosis [1, 2] . The 'diffuse uptake' pattern is suggestive of Graves' disease, and these patients are preferentially treated with anti-thyroid drugs [1, 2] . The 'patchy uptake' pattern is suggestive of toxic multinodular goitre (TMG), whereas the 'localised uptake' pattern suggests toxic adenoma (TA). Both TMG and TA are preferentially treated with radioiodine [1, 2] . Finally, diminished or absent uptake in a patient with thyrotoxicosis suggests thyroiditis, which is self-limiting and usually does not require treatment [1, 2] . the assessors. The 95% confidence interval of kappa statistics was calculated using kapci Stata package.
There was moderate inter-observer agreement in interpretation of thyroid scintigraphy. All three assessors were in agreement for 108 (63%, 95% CI 55-70%) scintigrams. The overall kappa for agreement for all four patterns of uptake was 0.60 (95% CI 0.55-0.61). The highest agreement was for 'diminished or no uptake' (kappa 0.88, 95% CI 0.85-0.92). This was followed by 'localised uptake' (kappa 0.63, 95% CI 0.52-0.73) and 'diffuse uptake' (kappa 0.56, 95% CI 0.50-0.57). The least agreement was observed with 'patchy uptake' (kappa 0.49, 95% CI 0.34-0.59). As expected, the agreement was higher between any two assessors rather than all three. Assessors 1 and 2 had 72% agreement (kappa 0.57), Assessors 1 and 3 had 75% agreement (kappa 0.65) and Assessors 2 and 3 had 73% agreement (kappa 0.59).
There was a potential for differential treatment in up to a third of patients due to inter-observer variation in interpretation of thyroid scintigraphy. In the scans that lacked agreement (n = 53) (Fig. 1) , Assessor 1 may have offered radioiodine as first-line treatment to 81% (n = 47) who were diagnosed with 'localised' or 'patchy' update, Assessor 2-15% (n = 10) and Assessor 3-69% (n = 45) of patients.
Our results show for the first time that there is significant variation in interpretation of the uptake pattern in thyroid scintigraphy. A previous study that assessed inter-observer agreement for thyroid volume and percentage uptake on thyroid scintigraphy ( 99m Tc-pertechnetate)
in patients with non-toxic nodular goitre showed poor to weak inter-observer agreement (kappa range 0.03-0.48) [4] . The lack of agreement may be due to technically poor quality scans such as differences in neck characteristics, problems of attenuation and unpredictable scatter characteristics [3] . Al-sheriff et al. [5] found that 13% of radioiodine thyroid scintigrams were inconclusive for patients with clinical thyrotoxicosis. Our study shows that thyroid scintigraphy may not provide definitive result in all cases. Non-agreement was seen in a third of cases. Agreement was good for 'diminished or no uptake' and supports its utility to diagnose thyroiditis. However, the weak agreement for 'diffuse' and 'patchy' patterns highlights the shortcomings of thyroid scintigraphy in distinguishing thyrotoxicosis due to TMG and Graves' disease. This result further supports the use of TRAb as the first-line investigation and thyroid scintigraphy as second-line except when there is a strong clinical suspicion of thyroiditis [1] .
Our study has limitations, in particular, the assessors were not nuclear medicine experts. It is possible that higher overall agreement would have been reached by radiologists with nuclear medicine expertise. However, in our experience of usual clinical practice in the UK, it is endocrinologists who usually make the decisions on scintigraphy patterns. Another possible reason for the moderate agreement in this study is the lack of consideration of clinical details when assessing the scans. In the routine clinical practice, clinicians have other clinical clues to the diagnosis. In summary, our study shows moderate inter-observer agreement in interpretation of thyroid scintigraphy, potentially affecting the choice of therapy for thyrotoxicosis. Ethical approval This study was not deemed to require research ethics committee approval under Governance Arrangements for Research Ethics Committees guidelines because it involved research undertaken by staff within a care team using information collected in the course of care of their patients, which was anonymised for this study.
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